Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cord blood transfusion in elderly AML consolidation
NCT04687657Phase 1Unknown
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Feb 2021
- Primary completion
- Feb 2024
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of umbilical cord blood in acute myeloid leukemia (AML), sponsored by First Affiliated Hospital of Xi'an Jiaotong University. Primary endpoint: Overall Survival at 2 years. Status: unknown.
02
Drugs
umbilical cord blood
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT04687657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04687657.